What Is Semax?

Semax is a synthetic peptide consisting of the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was originally developed from a fragment of adrenocorticotropic hormone (ACTH) and has been studied for neurotrophic, neuroprotective, and cognitive-supporting properties in experimental settings. Pasted text.txt

Researchers have reported that Semax exhibits a strong affinity for copper ions through its amino-terminal copper-binding motif, making it a candidate for studies investigating metal-ion regulation and oxidative stress pathways.

Copper, Reactive Oxygen Species, and Neurodegenerative Research

Copper is an essential trace element involved in numerous biological functions. However, under certain conditions, copper can participate in redox reactions that generate reactive oxygen species. Elevated ROS production has been associated with oxidative damage to proteins, lipids, and cellular structures. Pasted text.txt

In Alzheimer’s disease research, investigators have explored how copper may interact with amyloid-beta peptides, potentially contributing to oxidative stress and neuronal dysfunction. These mechanisms remain active areas of scientific investigation.

---

Key Findings from the Study

Researchers reported that Semax demonstrated the ability to bind copper ions and influence copper-mediated redox activity in laboratory models. The study found that Semax reduced copper-catalyzed ROS generation and decreased oxidative stress markers associated with amyloid-beta and copper interactions. Pasted text.txt

Additional experiments suggested that Semax could reduce cellular toxicity in cultured neuroblastoma cells exposed to copper-driven oxidative stress conditions. The authors proposed that these effects may be related to copper chelation and redox silencing mechanisms. Pasted text.tx

---

Why Researchers Are Interested in Semax

The ability to regulate metal-ion activity and oxidative stress remains a significant area of interest in neuroscience research. Investigators continue to explore whether compounds capable of modulating copper-associated ROS production may provide valuable insights into neurodegenerative disease mechanisms. Pasted text.txt

While additional research is necessary, Semax continues to be studied as a tool for understanding neuroprotection, oxidative stress regulation, and cellular resilience in experimental models.

---

Original Source

This article was inspired by and references findings published in:

Tomasello MF, Di Rosa MC, Naletova I, et al. Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of Aβ by Metal Ion Stripping and Redox Silencing. Bioinorganic Chemistry and Applications (2025).

Original Source: Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing

---

References

1. Tomasello MF, Di Rosa MC, Naletova I, et al.Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of Aβ by Metal Ion Stripping and Redox Silencing. Bioinorganic Chemistry and Applications. 2025. Pasted text.txt
2. Ashok BS, Ajith TA, Sivanesan S. Hypoxia-Inducible Factors as Neuroprotective Targets in Alzheimer’s Disease. Cellular and Molecular Neurobiology. 2017.
3. Crouch PJ, White AR, Bush AI. The Modulation of Metal Bioavailability as a Therapeutic Strategy for the Treatment of Alzheimer’s Disease. FEBS Journal. 2007.
4. Hureau C, Faller P. Abeta-Mediated ROS Production by Cu Ions: Molecular Mechanisms and Therapeutic Opportunities. Chemical Society Reviews. 2009.

The products listed below are intended for laboratory research and development purposes only. References to scientific literature are provided for educational and informational purposes.